2014 ACR/ARHP Annual Meeting Archives - Page 202 of 202

Abstract Number: 810

Damage Assessment in Takyasu Arteritis Using Takayasu Arteritis Damage Score (TADS)
Abstract Number: 25

DC-STAMP Modulates Osteoblast Differentiation and Regulates Bone Repair
Abstract Number: 341

Death Receptor 3 Causes Vascular Dysfunction in a Murine Model of Rheumatoid Arthritis
Abstract Number: 43

Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009
Abstract Number: 2506

Decrease in the Number of Peripheral Leukocytes and Neutrophils and Increase of the Percentage of Eosinophils at 4 Week Predict the DAS28-ESR Remission at 24 Weeks after Administration of Tocilizumab
Abstract Number: 2207

Decreased Bone Mineral Density in Patients with Ehler-Danlos Syndrome
Abstract Number: 1327

Decreased CD3-CD16CD56+ Natural Killer Cell Counts Are Associated with Disease Activity in Children with Orbital Myositis
Abstract Number: 2733

Decreased CXCR3+CCR4-CCR6+ CD4+ Effector Memory T Cells in Patients with Granulomatosis with Polyangiitis
Abstract Number: 670

Decreased Disease Activity and Corticosteroid Usage and No Renal Flares during Belimumab Treatment in Patients with Systemic Lupus Erythematosus
Abstract Number: 605

Decreased Frequencies of Circulating Follicular Helper T Cell Counterparts and Plasmablasts in Ankylosing Spondylitis Patients Naïve for TNF Blockers
Abstract Number: 637

Decreased Inflammatory Dendritic Cells in Lupus-Prone Estrogen Receptor Alpha Knockout (ERαKO) Mice Correlate with Increased Survival
Abstract Number: 2677

Decreased Levels of SRSF1 (Serin/Arginine-Rich Splicing Factor1) Induced Lower Levels of RasGRP1 in T Cells from Patients with Systemic Lupus Erythematosus
Abstract Number: 700

Decreased Lung Diffusion Capacity in Asymptomatic Patients with Systemic Lupus Erythematosus Does Not Predict Future Lung Disease
Abstract Number: 650

Decreased Severity of Pristane Induced Lupus in miR155 Deficient Mice
Abstract Number: 2094

Deep Sequencing Reveals Differential RNA Expression during Malignant Transformation in Major Salivary Glands in a Mouse Model of Sjogren’s Syndrome
Abstract Number: 1949

Defective PTEN Regulation and Function Contributes to B Cell Hyper-Responsiveness in Systemic Lupus Erythematosus
Abstract Number: 2087

Defective Regulation of L1 Endogenous Retroelements in Primary Sjogren’s Syndrome and Systemic Lupus Erythematosus: Role of Methylating Enzymes
Abstract Number: 2724

Deficiency of Ro52/TRIM21 in Different Subsets of Peripheral Blood Mononuclear Cells from Patients with Inflammatory Myopathies
Abstract Number: 1612

Deficient Repair of DNA Double-Strand Breaks and Increased Apoptosis in Patients with Lupus Nephritis
Abstract Number: 556

Defining Flare in Spondyloarthritis : Thresholds of Disease Activity Variations
Abstract Number: 2984

Degenerative Changes of the Spine on MRI in Patients with Inflammatory Back Pain from the DESIR Cohort
Abstract Number: 1157

Delay in Diagnosis from Onset of Symptoms By More Than One Year in 31% of Patients with Different Rheumatic Diseases in Australia
Abstract Number: 2794

Deletion of the Inhibitory Receptor Motif, ITIM, on DC-STAMP Alters Osteoclast Differentiation and Function
Abstract Number: 333

Deletion of the Prolactin Receptor Aggravates the Course of Antigen-Induced Arthritis
Abstract Number: 2327

Delivering ESCAPE-Pain (Enabling Self-Management and Coping of Arthritic Pain through Exercise ) – an Online Guide for Healthcare Professionals
Abstract Number: 1422

Demographic Differences in Health Related Information Technology Use Among Patients with Rheumatic Diseases
Abstract Number: 2292

Demographic, Clinical and Treatment Characteristics of the Childhood Arthritis and Rheumatology Research Alliance Registry Systemic JIA Cohort
Abstract Number: 1503

Demonstration of Functional Similarity Comparing Adalimumab to Biosimilar Candidate ABP 501
Abstract Number: 2264

Denosumab for Long-Term Glucocorticoid Users Who Have Inadequate Response to the Bisphosphonates: A 12-Month Randomized Control Trial
Abstract Number: 1795

Denosumab Restores Cortical Bone Loss at the Distal Radius Associated with Aging and Reduces Wrist Fracture Risk: Analyses from the Cross-over Group in the Extension of the Denosumab Pivotal Fracture Trial
Abstract Number: 195

Dependence on Walking Aids and Patient-Reported Outcomes after Total Knee Arthroplasty
Abstract Number: 196

Dependence on Walking Aids Is Associated with Pain and Mobility Limitation after Total Hip Arthroplasty
Abstract Number: 1742

Depletion of Reactive Oxygen Species Biases T Cells to Proinflammatory Cytokine Production in Rheumatoid Arthritis
Abstract Number: 653

Dermal Injury Promotes Nephritis Flare in Lupus-Prone NZM2328 Mice
Abstract Number: 113

Dermatologic Rheumatism: Our Experience with a Multidisciplinary Dermatology/Rheumatology Clinic
Abstract Number: 1995

Design and Implementation of a Clinical Teaching Tool for Approach to Children with Suspected New Rheumatologic Diagnosis
Abstract Number: 143

Detailed Anatomical Distribution of Synovial Inflammation Revealed By Ultrasound in Patients with Blau Syndrome
Abstract Number: 2339

Detecting Inflammation in Vivo Using Activatable Fluorescence Contrast Agents in Inflammatory Arthritis
Abstract Number: 4

Detection of Anti-Beta2glycoprotein I Domain 1 Antibodies By an Automated Chemiluminescence Assay in a Cohort of 400 Clinically Characterized Consecutive Routine Samples
Abstract Number: 770

Detection of Proteins in Lung Tissues of Patients with Systemic Sclerosis Using Tissue Microarrays
Abstract Number: 131

Detection of Synovitis and Erosions with an Automated Ultrasound System: Data from a Prospective Cohort with Early and Established RA
Abstract Number: 2390

Determinants and Impact of Early Initiation of Disease-Modifying Anti-Rheumatic Drug Therapy in Rheumatoid Arthritis
Abstract Number: 1857

Determinants of Annual Healthcare Utilization and Overall Cost of Care in Individuals with Systemic Lupus Erythematosus in a Large Insurance Claims Database: Glucocorticoid Use
Abstract Number: 1925

Determinants of Blood Hydroxychloroquine Concentration Variations in Systemic Lupus Erythematosus Patients
Abstract Number: 412

Determinants of Radiological Progression in Rheumatoid Arthritis: Relationship with Serum Levels of OPG, RANKL and DKK-1
Abstract Number: L14

Determination of Efficacy of Intra-Articular Infliximab Therapy in JIA Patients By 3D/4D Musculo-Skeletal Ultrasound
Abstract Number: 708

Determining Risk Factors That Increase Hospitalizations in Patients with Systemic Lupus Erythematosis
Abstract Number: 2997

Development and External Validation of a Five-Year Mortality Risk Stratification Tool for Early Diffuse Systemic Sclerosis Patients
Abstract Number: 357

Development and Validation of a Diagnostic Bead-Based Multiplex Autoantibody Assay:Screening for Autoantibodies to Detect “Seronegative” Rheumatoid Arthritis
Abstract Number: 2716

Development of a “Renal Crisis Prevention Card” As an Educational Tool Aimed at Improving Outcomes in High-Risk Patients with Systemic Sclerosis
Abstract Number: 771

Development of a Bifluorescent Lineage Tracker Reporter Mouse Strain to Analyze the Phenotypic Conversion of Endothelial Cells into Myofibroblasts in Vivo. Application to Study the Synergistic Effects of Endothelin-1 on TGF-β1-Induced Endothelial-to-Mesenchymal Transition
Abstract Number: 2999

Development of a Composite Index for Clinical Trials in Early Diffuse Cutaneous Systemic sclerosis—the Combined Response Index in Systemic Sclerosis
Abstract Number: 291

Development of a Serious Game Designed for Children with Juvenile Idiopathic Arthritis
Abstract Number: 1304

Development of an Index to Non-Invasively Quantify Lupus Nephritis Chronicity in Children
Abstract Number: 1939

Development of Cell–Based Enzyme–Linked Immunosorbent Assay for the Quantification of Anti–M–type phospholipase–a–receptor Antibodies and Its Clinical Usefulness in Patients with Membranous Nephropathy
Abstract Number: 896

Development of Fibromyalgia and Polysymptomatic Distress Definitions in the National Health Interview Survey
Abstract Number: 2009

Development of Multimedia Patient Education Tools (MM-PtET) for Osteoarthritis (OA), Osteoporosis (OP) and Rheumatoid Arthritis Patients (RA)
Abstract Number: 2831

Development of New Radiographic Vertebral Fractures in Patients with Ankylosing Spondylitis during 4 Years of TNF-α Blocking Therapy: Results from the Glas Cohort
Abstract Number: 259

Development of Pediatric Item Banks to Measure Pain Behavior in the Patient Reported Outcomes Measurement Information System
Abstract Number: 162

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises
Abstract Number: 2314

Dexa Testing in Long-Term Steroid Use
Abstract Number: 1265

Diabetes and Atorvastatin Are Potential Risk Factors for Statin-Associated Myopathy with Autoantibodies Against 3-Hydroxy-3-Methylglutaryl-Coenzyme a Reductase
Abstract Number: 2537

Diagnostic Accuracies of Sialography and Salivary Ultrasonography in Sjogren’s Syndrome Patients: A Meta-Analysis
Abstract Number: 372

Diagnostic Accuracy and Associated Costs of Rheumatoid Factor Testing in Primary Care: A Population-Based Cohort Study in Spain
Abstract Number: 2145

Diagnostic Performance and Disease Activity Assessment By FDG-PET in Large-Vessel Vasculitis: A Systematic Literature Review and Meta-Analysis
Abstract Number: 1193

Diagnostic value of Contrast-Enhanced MR-Angiography in diagnosing large Vessel Vasculitis
Abstract Number: 1463

Dickkopf-1 Perpetuated Synovial Fibroblast Activation and Synovial Angiogenesis in Rheumatoid Arthritis
Abstract Number: 2594

Differences in Localization and Activity of the Entheseal Involvement Between Non-Radiographic and Radiographic Axial Spondyloarthritis By the Ultrasound Assessment
Abstract Number: 197

Differences in Total Hip Replacement Outcomes Based on Age
Abstract Number: 194

Differences in Total Knee Replacement Outcomes Based on Age
Abstract Number: 2612

Different Performance of the Major Disease Activity Measures ASDAS and Basdai in Patients with Axial Spondyloarthritis Treated with Non-Steroidal Anti-Inflammatory Agents – Results from a Prospective Study
Abstract Number: 992

Differential Antigen-Presenting B-Cell Phenotype from Synovial Microenvironment of Rheumatoid Arthritis and Psoriatic Arthritis Patients
Abstract Number: 16

Differential Assay Reactivity of IgA Anti-B₂glycoprotein I Antibodies: Implications for Clinical Interpretation of Antiphospholipid Antibody Testing
Abstract Number: L8

Differential DNA Methylation Associated with Lupus Nephritis
Abstract Number: 1884

Differential DNA Methylation Associated with Rheumatoid Arthritis in Disease Discordant Monozygotic Twins
Abstract Number: 310

Differential Expression of microRNA in Monocytes from Children with Systemic Juvenile Idiopathic Arthritis: Implications for Polarized Phenotype
Abstract Number: 1415

Differential Gender Impact in the Quality of Life of Patients with Rheumatoid Arthritis. Comprehensive Study Including Clinical, Comorbidity and Psicho-Social Variables.
Abstract Number: 365

Differential Relative Contribution of Individual Components on DAS28 over Time: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada
Abstract Number: 600

Differing Patterns of Axial Spondyloarthritis in Females and Males
Abstract Number: 445

Differing Specificities of Anticitrullinated Peptide/Protein Antibodies in Palindromic Rheumatism and Rheumatoid Arthritis: A Case-Control Study
Abstract Number: 118

Difficult to Treat Gouty Arthritis Associated with Poor Health Related Quality of Life and High Resource Utilization: Post- Hoc Analysis
Abstract Number: 2576

Diffusing Weight Magnetic Resonance Imaging May Suggest the Treatment Strategy in Ankylosing Spondylitis
Abstract Number: 1171

Diffusion–weighted Magnetic Resonance Imaging (MRI) of Wrist and Hands in Patients with Rheumatoid arthritis –reproducibility and Correlation with Conventional MRI
Abstract Number: 576

Dikkopf-1 (Dkk-1) Serum Levels in Axial Spondyloarthritis (axSpA) Are Related to Disease Duration
Abstract Number: 2048

Disability in Discretionary Valued Life Activities and Self-Efficacy Explain a Significant Portion of RA Patients’ Global Assessments
Abstract Number: 959

Discoid Lupus Onset and Decrease Risk of Renal Disease in Patients with Systemic Lupus Erythematosus: Data from a Large Latin American Cohort
Abstract Number: 495

Discontinuation of Biologics in Patients with Rheumatoid Arthritis after Achieving Low-Activity Disease Status
Abstract Number: 269

Discontinuation of Concomitant Medication for Enthesitis-Related Arthritis during 52 Weeks of Treatment with Adalimumab
Abstract Number: 1820

Discordance of Hip Pain with Radiographic Hip Osteoarthritis: The Osteoarthritis Initiative
Abstract Number: 1491

Discovery and Characterization of COVA322, a Clinical Stage Bispecific TNF/IL-17A Inhibitor for the Treatment of Inflammatory Diseases
Abstract Number: 1484

Discovery of ARN-4079 – a Potent, Orally Available Dual Target Inhibitor of Janus Kinase 3 (JAK3) and Interleukin-2 Inducible T-Cell Kinase (ITK) for Rheumatoid Arthritis
Abstract Number: 543

Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol
Abstract Number: 1553

Disease Activity and Clinical Response Early in the Course of Treatment Predict Long-Term Outcomes in Psoriatic Arthritis Patients Treated with Certolizumab Pegol
Abstract Number: 2755

Disease Activity and Quality of Life in BEHÇET’S Disease: The Role of Patients Reportedoutcomes
Abstract Number: 2571

Disease Activity and Risk of Cardiovascular Disease in Patients with Ankylosing Spondylitis with High and Low Body Mass Index
Abstract Number: 1395

Disease Activity Is Associated with Insulin Resistance in Early Rheumatoid Arthritis
Abstract Number: 2578

Disease Activity Is the Major Determinant of Quality of Life and Physical Function in Patients with Early Axial Spondyloarthritis. Results from the Esperanza Cohort.
Abstract Number: 396

Disease Activity Scoring: Comparing Patient and Physician Global Assessment of Disease Activity in Rheumatoid Arthritis
Abstract Number: 575

Disease Activity Strongly Influences Work Productivity and Physical Health Related Quality of Life in Early Axial Spondyloarthritis: Data from the SPACE-Cohort
Abstract Number: 270

Disease Burden Is Comparable in Children with Enthesitis-Related Arthritis and Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 1383

Disease Characteristics and RA Development in Undifferentiated Arthritis: A 2-Year Follow-up Study of 413 Patients with Arthritis of Less Than 16 Weeks Duration
Abstract Number: 2598

Disease Characteristics Associated with the Presence of Dactylitis in Patients with EARLY Spondyloarthritis: Results from Esperenza Cohort
Abstract Number: 1386

Disease Flares during 10 Year Follow-up in Patients with Rheumatoid Arthritis Are Associated with Joint Damage Progression and Disability
Abstract Number: 1911

Disease Modifying Anti-Rheumatic Drug Use and the Risk of Incident Hyperlipidemia in Patients with Early Rheumatoid Arthritis: A Retrospective Cohort Study
Abstract Number: 1636

Disease Phenotype Is Associated with TH1, TH2 and TH17 Cytokines in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 945

Disease Remission Reduces Risk of Heart Failure in Rheumatoid Arthritis Patients Independent of Treatment Strategy
Abstract Number: 1534

Disease Severity and Treatment of Rheumatoid Arthritis: A Comparative Study Between Sudan and Sweden
Abstract Number: 1673

Disease Specific Quality of Life in Patients with Lupus Nephritis
Abstract Number: 1518

Disentangling the Effects of Tocilizumab on Neutrophil Survival and Function
Abstract Number: 1955

Disparity in Internalisation of Monoclonal Antibodies Targeting B Cell Antigens and Regulation By Fc Gamma Receptor IIb: Implications for Targeted Therapy in SLE
Abstract Number: 2281

Dissecting the Heterogeneity of Macrophage Activation Syndrome
Abstract Number: 751

Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis
Abstract Number: 1609

Dissection of the Type I Interferon Response in Systemic Lupus Erythematosus : Serum IFNα Is Elevated in Lupus Nephritis and Correlates with IFN Score; IFNβ Is Elevated in Mucocutaneous Disease
Abstract Number: 657

Distinct Contributions of C1q and C3 in Preventing Immunogenicity of Apoptotic Cells in Lupus
Abstract Number: 524

Distinct Patterns of DNA Methylation in Labial Salivary Gland Tissue Based on Sjögren’s Syndrome Disease Status
Abstract Number: 438

Distinct Profiles of Proinflammatory Macrophages in Rheumatoid Arthritis and Coronary Artery Disease
Abstract Number: 1541

Distinct Regulation of T Helper Cell Differentiation By Biologic DMARD Therapy in Rheumatoid Arthritis
Abstract Number: 2977

Distinct Serum Protein Signature and Novel Biomarkers of primary Sjogren’s Syndrome Revealed by comprehensive High-Throughput Proteomic Analysis
Abstract Number: 2816

Distinctive DNA Methylome Signatures in Early Rheumatoid Arthritis (RA) Synoviocytes Compared with Longstanding (RA) and Other Inflammatory Arthritides
Abstract Number: 1270

Distinctive Muscle Histopathological Features of Anti-Synthetase Syndrome
Abstract Number: 757

Distinctive Patterns of Telomere Shortening and Apoptosis in Limited and Diffuse cutaneous Systemic Sclerosis
Abstract Number: 381

Distribution and Clinical Significance of Anti-Heterogenic Nuclear Ribonucleoprotein A2 Antibody in Connective Tissue Diseases
Abstract Number: 185

Distribution of Haemochromatosis Arthropathy. High Ankle and Mid Foot Prevalence; A Diagnostic Clue ?
Abstract Number: 2388

DMARD Use after an Initial Acute MI Is Associated with Reduced Risk of a Recurrent Event and Mortality
Abstract Number: 2680

DNA Hydroxymethylation Changes in CD4+T Cells from Patients with Systemic Lupus Erythematosus
Abstract Number: 2448

DNA Methylation Analysis of Lymph Node Stromal Cells of Rheumatoid Arthritis Patients
Abstract Number: 881

DNA Methylation Analysis of the Temporal Artery Microenvironment Reveals a Robust T Cell Signature and Suggests a Role for TNF-α in Giant Cell Arteritis
Abstract Number: 2446

DNA Methylation Profiles That Distinguish Rheumatoid Arthritis from Osteoarthritis in Fibroblast-like Synoviocytes Can be Detected in Immune Cells from Peripheral Blood
Abstract Number: 1813

DNA Sensors Regulate Inflammation in a Model of Autoimmune Arthritis
Abstract Number: 594

Do Bone Marrow Edema Lesions in the Sacroiliac Joint Change into Fatty Lesions over a 1-Year Period in Patients with Axial Spondyloarthritis or Possible Spondyloarthritis
Abstract Number: 574

Do Extra-Articular Manifestations Influence Outcome in Ankylosing Spondylitis? a 12 Year Follow-up Study
Abstract Number: 2060

Do Fibromyalgia Patients Have a Distinct Sleep Signature?
Abstract Number: 1467

Do G-CSF and Neutrophils Contribute to the Pathophysiology of Rheumatoid Arthritis?
Abstract Number: 2018

Do Mediterranean or Vegetarian Diets Influence Risk of Rheumatoid Arthritis?
Abstract Number: 2599

Do Patients Diagnosed As Axial Spondyloarthritis (AxSpA) Who Have Primary Inefficacy to Anti-TNF Really Have AxSpA? a Five-Year Follow-up Study of 27 Patients with Primary Inefficacy to Anti-TNF
Abstract Number: 1182

Do Patients with Active RA Also Have Inflamed Atherosclerotic Plaques on PET-MRI?
Abstract Number: 2574

Do Patients with Axial Spondyloarthritis (AxSpA) Perform Enough Physical Activity? a Cross-Sectional Study of 207 Patients
Abstract Number: 491

Do Patients with Congestive Heart Failure Treated with Biologics for RA Have a Lower Risk of Fatal Outcome of Serious Infections?
Abstract Number: 2940

Do Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Respond Similarly Well to Nsaids? – a Prospective Study Including Magnetic Resonance Imaging
Abstract Number: 2416

Do Patterns of Joint Swelling or Tenderness in Rheumatoid Arthritis Patients Impact Disease Activity Outcomes and Pain? Implications for Clinical Practice
Abstract Number: 2554

Do TNF Alpha Inhibitors Have an NSAID Sparing Effect in Real Life in Early Axial Spa? Results from the DESIR Cohort
Abstract Number: 132

Do Ultrasound (PDUS) and DAS28 Measure Different Aspects of Disease Activity? Analyses from the First Prospective International Phase IIIb Study of PDUS Response in Abatacept-Treated Patients with Rheumatoid Arthritis (RA)
Abstract Number: 2608

Do You Assess Gastro-Intestinal Auto-Antibodies and Symptoms in Patients with Spondyloarthritis?
Abstract Number: 351

Doctor, Will My Fatigue be Better If I’m in Remission? an Exploratory Analysis of 1284 Rheumatoid Arthritis (RA) Patients Indicates Fatigue Is the Only Aspect of Patient-Perceived Impact to Remain Significant in ACR/EULAR Boolean Remission
Abstract Number: 2890

Does a Family History of RA Influence the Clinical Presentation and Treatment Response in RA?
Abstract Number: 926

Does a Family History of Total Knee Replacement for Knee Osteoarthritis Influence Knee Pain and Structural Progression? a Prospective Longitudinal Cohort Study
Abstract Number: 503

Does a Higher Dose of Folic Acid Reduce Adverse Effects of Methotrexate in Rheumatoid Arthritis? a Randomized Controlled Trial
Abstract Number: 2273

Does a Standardized Multidisciplinary Approach Improve Outcomes for Children with NMDA Receptor Antibody Encephalitis? : A Preliminary Assessment of a Single Center Experience
Abstract Number: 239

Does Adjusting BMI for Lean Mass Deficits Affect Calculated Fracture Risk Using FRAX in Rheumatoid Arthritis?
Abstract Number: 1657

Does Advanced Age Influence the Type of Renal Injury and the Prognosis of Lupus Nephritis?
Abstract Number: 1309

Does Anti-C1q Antibody Have Diagnostic and Prognostic Roles in Childhood – Onset Systemic Lupus Erythematosus?
Abstract Number: 1092

Does Arthritis Status Predict Starting or Stopping Work over a 2-Year Period?
Abstract Number: 2492

Does Body Mass Index Impact Long-Term Retention with Abatacept in Patients with RA Who Have Received at Least One Prior Biologic Agent? 2-Year Results from a Real-World, International, Prospective Study
Abstract Number: 2913

Does Corticosteroid Therapy at Disease Onset Influence Disease Progression of RA? Results from the Swiss Prospective Observational Cohort
Abstract Number: 2225

Does Previous Corticosteroid Treatment Affect the Inflammatory Infiltrate Found in Polymyositis Muscle Biopsies?
Abstract Number: 1993

Does Psychological Safety Impact Learning Environments Among Rheumatology Fellows: Findings from Veterans Affairs Learners’ Perception Survey
Abstract Number: 3014

Does the Order or Amount of Risk-Benefit Information Presented Influence patients’ Perceived Value of a Proposed New Medication?
Abstract Number: 1480

Dose Selection of GLPG0634, a Selective JAK1 Inhibitor, for Rheumatoid Arthritis Phase 2B Studies: PK/PD and Exposure-DAS28 Modeling Approach
Abstract Number: 515

Dosing of Intravenous Tocilizumab in a Real-World Setting—Analyses from a US RA Registry
Abstract Number: 370

Double Positivity of RA Serologies More Prevalent Yet Associated with Clinical Response in Ethnic Minority Patients with Rheumatoid Arthritis
Abstract Number: 530

Downregulation of Microrna-183 in Sjogren’s Syndrome Minor Salivary Glands. Implications in Control of Ezrin Expression and Salivary Gland Function
Abstract Number: 2450

Downregulation of Mirna-196a and Its Downstream HOXC8 Target Gene in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 285

Drug Safety in Treatment of Juvenile Idiopathic Arthritis (JIA): Biologic Therapy Compared with MTX
Abstract Number: 2776

Drug-Associated Cutaneous Vasculitis: Study of 239 Patients from a Single Referral Center
Abstract Number: 1686

DUAL Energy Computed Tomography for the Evaluation of Calcinosis in Systemic Sclerosis
Abstract Number: 2148

Dual Energy CT Scanning: Variable Sensitivity for Gout in Non-Tophaceous and Tophaceous Disease and in Individual Erosions
Abstract Number: 2820

Dual Role for B Cells in Promoting Bone Erosion in Rheumatoid Arthritis Via Effects on Osteoclast and Osteoblast Differentiation
Abstract Number: 2380

Durability of First Biologic Is Not Influenced By Initial/Early DAS28
Abstract Number: 219

DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort
Abstract Number: 1180

Dynamic Magnetic Resonance Imaging in the Assessment of the Response to Certolizumab Pegol in Rheumatoid Arthritis Patients: Results from a Phase IIIb Randomized Study
Abstract Number: 661

Dysfunction of Glycosphingolipid Metabolism in Lupus Nephritis
Abstract Number: 1040

Dysregulated Serum Interleukin 16 Concentration Associated with Clinical Disease Activity in Patients with Rheumatoid Arthritis Is Efficiently Corrected By Immunological Intervention
Abstract Number: 1957

Dysregulation of CC Chemokines at Microvascular Endothelial Cells of Blood and Lymphatic Vessels Under Inflammatory Conditions